These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35506967)

  • 21. Medication-related osteonecrosis of the jaws associated with intravitreal administration of ranibizumab.
    Oz I; Kaplan I; Kleinman S; Arbel S; Shuster A
    Int J Oral Maxillofac Surg; 2020 Dec; 49(12):1589-1591. PubMed ID: 32616306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of segmental mandibular resection without microvascular reconstruction in patients affected by medication-related osteonecrosis of the jaw: a systematic review.
    Sacco R; Umar G; Guerra RC; Akintola O
    Br J Oral Maxillofac Surg; 2021 Jul; 59(6):648-660. PubMed ID: 34023155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Study of Oral Health Parameters and the Properties and Composition of Saliva in Oncological Patients with and without Medication-Related Osteonecrosis of the Jaw Who Take Bisphosphonates.
    Sobczak-Jaskow H; Kochańska B; Drogoszewska B
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374277
    [No Abstract]   [Full Text] [Related]  

  • 24. In Vitro Cytotoxicity of Antiresorptive and Antiangiogenic Compounds on Oral Tissues Contributing to MRONJ: Systematic Review.
    Guirguis RH; Tan LP; Hicks RM; Hasan A; Duong TD; Hu X; Hng JYS; Hadi MH; Owuama HC; Matthyssen T; McCullough M; Canfora F; Paolini R; Celentano A
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency.
    Dalle Carbonare L; Mottes M; Valenti MT
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33567797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals.
    Acharya S; Patil V; Ravindranath V; Kudva A; Nikhil K
    J Med Life; 2022 Mar; 15(3):368-373. PubMed ID: 35449990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study.
    Sakamoto Y; Sawada S; Kojima Y
    Sci Rep; 2023 Aug; 13(1):12890. PubMed ID: 37558709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw.
    Obermeier KT; Dewenter I; Malenova Y; Fliefel R; Kaeppler G; Otto S
    Sci Rep; 2024 Apr; 14(1):7914. PubMed ID: 38575664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention.
    Di Fede O; Panzarella V; Mauceri R; Fusco V; Bedogni A; Lo Muzio L; Sipmo Onj Board ; Campisi G
    Biomed Res Int; 2018; 2018():2684924. PubMed ID: 30306086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous bilateral osteonecrosis of the mandible in a bisphosphonate-naive patient.
    Sklavos AW; Delpachitra SN; Thomas AM; Nastri A
    Br J Oral Maxillofac Surg; 2019 Apr; 57(3):271-274. PubMed ID: 30773304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication-related osteonecrosis of the jaw triggered by endodontic failure in oncologic patients.
    Tempesta A; Capodiferro S; Di Nanna S; D'Agostino S; Dolci M; Scarano A; Gambarini G; Maiorano E; Favia G; Limongelli L
    Oral Dis; 2023 Oct; 29(7):2799-2805. PubMed ID: 36403223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
    Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
    J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
    Shibahara T
    Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiopathic lingual mandibular sequestration and its relationship to medication-related osteonecrosis of the jaws (MRONJ): mini review.
    Vyas R; Gohel A; Escoffier C; Shan K; Katz J
    Quintessence Int; 2022 Oct; 53(10):868-873. PubMed ID: 36169274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
    Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?
    Ueda N; Nakashima C; Aoki K; Shimotsuji H; Nakaue K; Yoshioka H; Kurokawa S; Imai Y; Kirita T
    Clin Oral Investig; 2021 May; 25(5):3087-3093. PubMed ID: 33057886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awareness About Medication-Related Osteonecrosis of the Jaw Among Dental Professionals: A Multicentre Study.
    Patil V; Acharya S; Vineetha R; Nikhil K
    Oral Health Prev Dent; 2020 Jul; 18(3):505-509. PubMed ID: 32016175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case series of medication-related osteonecrosis of the jaw (MRONJ) patients prescribed a drug holiday.
    Hamid A; Thomas S; Bell C; Gormley M
    Br J Oral Maxillofac Surg; 2023 Apr; 61(3):227-232. PubMed ID: 36935312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
    Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
    Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jaw.
    Schwaneck EC; Streit A; Krone M; Hartmann S; Müller-Richter U; Kübler AC; Gadeholt O; Schmalzing M; Tony HP; Brands RC
    Z Rheumatol; 2020 Mar; 79(2):203-209. PubMed ID: 30796524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.